MLL-ENL and Flt3 ITD murine AML cells overexpressing MN1 led to a statistically significant shortening of survival in syngeneic recipients when compared to GFP-only cells in both treated and control groups. This evidence concerns the gene KMT2A and acute myeloid leukemia.